Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SeaStar Medical Holding Corp ICU

Healthcare Medical Devices
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies... see more

Recent & Breaking News (NDAQ:ICU)

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

GlobeNewswire 1 day ago

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

GlobeNewswire 8 days ago

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire 10 days ago

FDA Grants Breakthrough Device Designation for SeaStar Medical's Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

GlobeNewswire November 6, 2024

Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial

GlobeNewswire November 1, 2024

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

GlobeNewswire October 31, 2024

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

GlobeNewswire October 25, 2024

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

GlobeNewswire October 25, 2024

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial

GlobeNewswire October 23, 2024

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

GlobeNewswire October 22, 2024

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

GlobeNewswire October 18, 2024

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

GlobeNewswire October 15, 2024

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire October 9, 2024

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

GlobeNewswire October 8, 2024

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial

GlobeNewswire September 25, 2024

The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against SeaStar Medical Holding Corporation

Accesswire September 15, 2024

SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Regulations And Stockholders Are Invited To Help The Schall Law Firm

Accesswire September 14, 2024

The Schall Law Firm Urges Investors To Take Part In A Securities Fraud Case Against SeaStar Medical Holding Corporation

Accesswire September 13, 2024

SeaStar Medical Holding Corporation Is Being Sued For Securities Law Violations And Stakeholders Are Invited To Reach Out To The Schall Law Firm

Accesswire September 12, 2024

The Schall Law Firm Urges Investor Participation In A Securities Fraud Case Against SeaStar Medical Holding Corporation

Accesswire September 11, 2024